ENDP

Endo International plc News Headlines

$63.82
*  
0.11
0.17%
Get ENDP Alerts
*Delayed - data as of Sep. 2, 2014  -  Find a broker to begin trading ENDP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog
9/2/2014 4:45:00 PM - Zacks.com

Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes - Analyst Blog
9/2/2014 3:00:00 PM - Zacks.com

Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog
9/2/2014 2:50:00 PM - Zacks.com

Why Endo International Can Deliver Solid Rewards With Minimal Risk
9/2/2014 2:31:00 PM - TheStreet

Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog
8/29/2014 5:10:00 PM - Zacks.com

IGI, Laboratories, Inc. (IG) in Focus: Stock Rises 5.8% - Tale of the Tape
8/29/2014 9:32:00 AM - Zacks.com

Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog
8/27/2014 9:49:00 AM - Zacks.com

OncoGenex's Custirsen Passes First Interim Futility Analysis - Analyst Blog
8/22/2014 5:40:00 PM - Zacks.com

Auxilium Pharmaceuticals Up on Mid-Stage Data on Xiaflex - Analyst Blog
8/22/2014 5:25:00 PM - Zacks.com

AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog
8/22/2014 5:00:00 PM - Zacks.com

Supernus' Trokendi XR Faces Generic Threat from Actavis - Analyst Blog
8/22/2014 4:55:00 PM - Zacks.com

Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog
8/22/2014 4:50:00 PM - Zacks.com

Flamel Technologies SA (FLML) in Focus: Stock Rises 8% - Tale of the Tape
8/22/2014 9:32:00 AM - Zacks.com

Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog
8/21/2014 5:30:00 PM - Zacks.com

Gilead (GILD) Hits 52-Week High Thanks to Sovaldi - Analyst Blog
8/21/2014 9:56:00 AM - Zacks.com

Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX - Analyst Blog
8/20/2014 6:21:00 PM - Zacks.com

Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan - Analyst Blog
8/20/2014 4:45:00 PM - Zacks.com

Salix Pharmaceuticals (SLXP) Jumps: Stock Moves 15.5% Higher - Tale of the Tape
8/20/2014 9:46:00 AM - Zacks.com

Falling Earnings Estimates Signal Weakness Ahead for Egalet (EGLT) - Tale of the Tape
8/20/2014 8:46:00 AM - Zacks.com

Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog
8/19/2014 5:10:00 PM - Zacks.com

AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog
8/18/2014 5:20:00 PM - Zacks.com

AstraZeneca's Gout Drug in Focus with Phase III Data Readout - Analyst Blog
8/15/2014 4:45:00 PM - Zacks.com

Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed - Analyst Blog
8/15/2014 9:00:00 AM - Zacks.com

Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog
8/14/2014 3:30:00 PM - Zacks.com

Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update - Analyst Blog
8/14/2014 10:58:00 AM - Zacks.com